Bavarian Nordic A/S (BVNRY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,835	2,065	2,051	2,164	2,892	1,793
Market Cap Growth	-3.32%	0.69%	-5.24%	-25.15%	61.27%	115.45%
Enterprise Value	2,662	1,821	1,843	1,837	2,631	1,449
Last Close Price	12.17	8.71	8.74	10.15	13.45	10.75
PE Ratio	14.81	15.06	9.38	-	-	39.31
PS Ratio	3.14	2.60	1.96	4.78	9.96	5.89
PB Ratio	1.69	1.30	1.34	2.11	2.56	2.23
P/TBV Ratio	3.68	2.93	3.59	12.48	12.04	-
P/FCF Ratio	18.78	7.97	14.16	-	-	31.26
P/OCF Ratio	17.35	7.63	12.36	68.46	-	19.08
EV/Sales Ratio	2.76	2.30	1.76	4.06	9.06	4.76
EV/EBITDA Ratio	8.32	8.06	4.73	44.04	480.48	12.46
EV/EBIT Ratio	11.91	12.40	5.85	-	-	22.29
EV/FCF Ratio	17.63	7.03	12.73	-	-	25.26
Debt / Equity Ratio	0.01	0.01	0.01	0.17	0.13	0.10
Debt / EBITDA Ratio	0.06	0.08	0.05	3.83	17.43	0.65
Debt / FCF Ratio	0.11	0.07	0.15	-	-	1.35
Asset Turnover	0.46	0.40	0.53	0.26	0.18	0.23
Inventory Turnover	1.41	1.46	1.92	2.07	2.65	3.79
Quick Ratio	1.35	1.21	1.33	1.48	2.18	1.94
Current Ratio	2.81	2.07	1.94	1.96	2.49	2.50
Return on Equity (ROE)	12.16%	9.09%	16.87%	-4.78%	-7.58%	8.21%
Return on Assets (ROA)	6.65%	4.60%	9.93%	-0.36%	-1.88%	3.13%
Return on Capital (ROIC)	8.22%	6.01%	14.10%	-0.53%	-2.85%	5.46%
Return on Capital Employed (ROCE)	12.30%	9.10%	18.40%	-	-	5.10%
Earnings Yield	6.75%	6.64%	10.67%	-2.31%	-2.46%	2.54%
FCF Yield	5.33%	12.55%	7.06%	-0.94%	-4.45%	3.20%
Buyback Yield / Dilution	-2.52%	-1.82%	-8.94%	-11.59%	-16.76%	-67.42%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.